CSI Market
Sign In | Register

Propanc Biopharma Inc (PPCH) Annual Balance Sheets

Annual · GAAP · USD millions
Access PPCH quarterly Balance Sheets →
From Propanc Biopharma Inc through Jun 30 2022, shifts in Jun 30 2026's assets and liabilities provide insight into the company's capital structure and financial stability.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
(Jun 30 2025) (Jun 30 2024) (Jun 30 2023) (Jun 30 2022)
Assets
Cash & cash equivalent0.83
Cash & Short-term Investments0.00
Value Added Tax Receivable, Current0.00
Other Current Assets0.05
Prepaid Expense, Current AS7.66
Total Current Assets8.54
Equipment/Property/Plant Net0.03
Deposits Assets, Noncurrent AS0.00
Tax Assets, Noncurrent27.51
Prepaid Expense, Noncurrent, Total PR4.19
Other Assets, Noncurrent0.00
Goods And Services Tax Receivable Current0.01
Operating Lease Right Of Use Asset0.06
Total Assets12.78
Liabilities
Accounts Payable, Current AC1.13
Accrued Liabilities, Current0.75
Derivative Liability LI0.00
Convertible Debt, Current LO0.00
Other Liabilities, Current1.47
Total Current Liabilities3.35
Long-term debt0.00
Long-term Debt Convertible0.20
Total Long-term Debt0.20
Accrued Income Taxes, Noncurrent3.05
Other liabilities, Noncurrent0.00
Operating Lease Liability Current-
Operating Lease Liability Noncurrent-
Total Liabilities3.38
Stockholders' Equity
Subscription Receivable-
Common Stock Value0.00
Treasury Stock Value0.05
Additional Paid In Capital Common Stock152.75
Retained Earnings / Accumulated Deficit-144.48
Accumulated Other Comprehensive Income1.18
Other Equity1.18
Common Stockholder's Equity9.40
Preferred Stockholder's Equity0.00
Total Stockholder's Equity9.40
Liabilities & Stockholder's Equity12.78
4 historic quarters locked

Sign in to unlock the full Propanc Biopharma Inc balance sheet history.

Sign In Create Free Account

About Propanc Biopharma Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20260630)
  • Filed with the SEC: September 25, 2026
  • Source: form10-k.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-26-044373

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License